Pm8002

Other Medications

EU Experimental ES Not available 2 Clinical Trials

Description

Pm8002 (also known as BNT327) is an experimental drug being studied in clinical trials for metastatic colorectal cancer. It is being tested in combination with chemotherapy. The goal of the trial is to see if adding Pm8002 to chemotherapy can help patients with advanced colorectal cancer. The trial is designed to compare different doses of Pm8002 combined with chemotherapy. It is being studied in patients with both MSI-H (microsatellite instability-high) and MSS (microsatellite stable) tumors. This drug is not yet approved for use in colorectal cancer.

Mechanism of Action

Pm8002 is currently being studied in clinical trials. The specific way it works (its mechanism of action) is being investigated. It is being tested in combination with chemotherapy to see if it can improve outcomes for patients with metastatic colorectal cancer.

Side Effects

As Pm8002 is an investigational drug Its side effects are still being evaluated in ongoing clinical trials. The specific side effects and how common they are are not yet fully known. Patients participating in the trials are closely monitored for any adverse events.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT07133750 Phase 2
Recruiting
PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
China
NCT05918445 Phase 1
Recruiting
PM8002 in the Treatment of Patients With Advanced Solid Tumors
China

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials2
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
785 trials
Leucovorin
Other Medications
646 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.